These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. Zolnierczyk JD; Błoński JZ; Robak T; Kiliańska ZM; Wesierska-Gadek J Ann N Y Acad Sci; 2009 Aug; 1171():124-31. PubMed ID: 19723046 [TBL] [Abstract][Full Text] [Related]
3. A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. Alvi AJ; Austen B; Weston VJ; Fegan C; MacCallum D; Gianella-Borradori A; Lane DP; Hubank M; Powell JE; Wei W; Taylor AM; Moss PA; Stankovic T Blood; 2005 Jun; 105(11):4484-91. PubMed ID: 15692065 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells. Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892 [TBL] [Abstract][Full Text] [Related]
5. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia. Chen R; Wierda WG; Chubb S; Hawtin RE; Fox JA; Keating MJ; Gandhi V; Plunkett W Blood; 2009 May; 113(19):4637-45. PubMed ID: 19234140 [TBL] [Abstract][Full Text] [Related]
7. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
9. R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. Rogalińska M; Błoński JZ; Komina O; Góralski P; Zołnierczyk JD; Piekarski H; Robak T; Kiliańska ZM; Wesierska-Gadek J J Cell Biochem; 2010 Jan; 109(1):217-35. PubMed ID: 19911397 [TBL] [Abstract][Full Text] [Related]
10. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986 [TBL] [Abstract][Full Text] [Related]
11. [Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine]. Gao JX; Zhou YQ; Zhang RH; Ma XL; Liu KJ Sheng Li Xue Bao; 2005 Dec; 57(6):755-60. PubMed ID: 16344902 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas. Lacrima K; Valentini A; Lambertini C; Taborelli M; Rinaldi A; Zucca E; Catapano C; Cavalli F; Gianella-Borradori A; Maccallum DE; Bertoni F Ann Oncol; 2005 Jul; 16(7):1169-76. PubMed ID: 15851403 [TBL] [Abstract][Full Text] [Related]
13. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Pepper C; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C Blood; 2003 Apr; 101(7):2454-60. PubMed ID: 12446453 [TBL] [Abstract][Full Text] [Related]
14. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine. Paprskárová M; Krystof V; Jorda R; Dzubák P; Hajdúch M; Wesierska-Gadek J; Strnad M J Cell Biochem; 2009 Jun; 107(3):428-37. PubMed ID: 19308936 [TBL] [Abstract][Full Text] [Related]
15. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Chen S; Dai Y; Harada H; Dent P; Grant S Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790 [TBL] [Abstract][Full Text] [Related]
16. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia. McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055 [TBL] [Abstract][Full Text] [Related]
17. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Somerville L; Cory JG Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634 [TBL] [Abstract][Full Text] [Related]
18. Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl‑2. Coker-Gurkan A; Arisan ED; Obakan P; Ozfiliz P; Kose B; Bickici G; Palavan-Unsal N Mol Med Rep; 2015 Mar; 11(3):1968-74. PubMed ID: 25378060 [TBL] [Abstract][Full Text] [Related]
19. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation. Pepper C; Ali K; Thomas A; Hoy T; Fegan C; Chowdary P; Kell J; Bentley P Eur J Haematol; 2002 Oct; 69(4):227-35. PubMed ID: 12431242 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target. Decker T; Hipp S; Hahntow I; Schneller F; Peschel C Br J Haematol; 2004 Apr; 125(2):141-8. PubMed ID: 15059135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]